Driving the Market: Special Research on Twitter, Frontline, CytRx, Tonix and American Electric
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, January 7, 2015 /PRNewswire/ --
Moments ago, Analysts Review released new research updates concerning several important developing situations including Twitter (NYSE: TWTR), Frontline (NYSE: FRO), CytRx (NASDAQ: CYTR), Tonix (NASDAQ: TNXP), and American Electric (NYSE: AEP). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
To access our full PDF reports on a complementary basis, please visit the links below.
--
Today's update concerns the following companies:
============
Full PDF Download Links (you may have to copy and paste the following links into your browser):
TWTR Research Report: ( http://get.analystsreview.com/pdf/?c=Twitter&d=07-Jan-2015&s=TWTR ),
FRO Research Report: ( http://get.analystsreview.com/pdf/?c=Frontline&d=07-Jan-2015&s=FRO ),
CYTR Research Report: ( http://get.analystsreview.com/pdf/?c=CytRx&d=07-Jan-2015&s=CYTR ),
TNXP Research Report: ( http://get.analystsreview.com/pdf/?c=Tonix&d=07-Jan-2015&s=TNXP ),
AEP Research Report: ( http://get.analystsreview.com/pdf/?c=American%20Electric&d=07-Jan-2015&s=AEP ).
============
--
Analyst Update: Experts' Comments,Positive Clinical Study Results, and Divestment Plans
Reviewed by: Rohit Tuli, CFA®
It's almost a week into the New Year now and global market sell-off shows no signs of easing yet. The U.S. markets fell again on Tuesday, January 6, with S&P 500 index continuing its southward journey for the fifth consecutive session. Steadily declining oil prices and uncertainty ahead of the Greek vote which may determine Greece's future in the Eurozone kept global investors jittery. The Dow Jones Industrial Average ended the session lower by 0.74% at 17,371.64, the S&P 500 ended 0.89% down at 2,002.46, and the Nasdaq Composite finished 1.29% down at 4,592.74. The European markets also closed lower on Tuesday as Euro slumped to nine-year low levels against the greenback, driven by the concerns over political turmoil in Greece. Meanwhile, Asian markets were also under pressure on Tuesday as Eurozone worries coupled with growth concerns over China rattled investors.
Shares of Twitter Inc. (Twitter) jumped over 6.5% on Tuesday in an otherwise slumping equity market after a former Yahoo CEO Ross Levinsohn suggested that the California-based microblogging site should buy Yahoo's core business. According to a Wall Street Journal report, a SunTrust analyst last month also floated Levinsohn's name as potential successor of Twitter CEO Dick Costolo. Continue reading about the story in our exclusive research report.
Shares of Frontline Ltd. (Frontline), the world's largest oil tanker shipping company, rallied over 23% on Tuesday, January 6, after bullish comments from Karen Finerman on CNBC's Fast Money. Finerman noted the Frontline stock as a leveraged play in the shipping sector, according to The Street's report. Find out more about Frontline and analyst's comments in our exclusive research report.
CytRx Corporation (CytRx) announced positive interim results from its ongoing Phase 2 clinical trial with aldoxorubicin for the treatment of unresectable glioblastoma multiforme (GBM), a deadly form of brain cancer. According to CytRx, aldoxorubicin showed a complete response, tumor shrinkage, prolonged stable disease, and favorable tolerability in patients. For additional details on the Company's Phase-2 trial with aldoxorubicin, please read our research report.
Shares of Tonix Pharmaceuticals Holding Corp. (Tonix) rallied 26.50% on Tuesday, January 6, after the Company announced that it has received written guidance from the U.S. Food and Drug Administration (FDA) on its Phase 3 clinical study design for TNX-102 SL in fibromyalgia. Know more about the latest FDA boost for Toxin's Phase 3 clinical study in our exclusive research report.
American Electric Power Company, Inc. (American Electric) is looking to sell seven power plants in Ohio and Indiana amid falling electricity prices, Bloomberg reported. The Company has hired Goldman Sachs Group Inc. as its adviser for the sale of plants having capacity of 7,923 megawatts. Read our complete research report to know more about the American Electric's plans to sell power plants.
--
About Analysts Review
At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.
--
Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article